Tumor Antigen-sensitized DC Vaccine As an Adjuvant Therapy for Esophagus Cancer
Clinical trial NCT05023928 · COMPLETED
Trial details
- NCT number
- NCT05023928
- Sponsor
- Sichuan University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-01
- Primary completion
- 2023-10-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.